
    
      PROTOCOL OUTLINE: Patients receive fludarabine IV over 2 hours on days -4 to -2 followed by
      total body irradiation and peripheral blood stem cell or bone marrow transplantation on day
      0. Patients also receive oral or IV cyclosporine 2-3 times daily on days -3 to 50 (related
      donor) or 100 (unrelated donor) and oral mycophenolate mofetil twice daily on days 0 to 28
      (related donor) or 40 (unrelated donor).

      Patients may also receive donor lymphocyte infusion for continued treatment of symptoms in
      the event of mixed chimerism and in the absence of graft-versus-host disease.

      Patients are followed weekly for 1 month, monthly for 2 years, and then annually thereafter.
    
  